Srikripa Devarakonda Score: 47
Analyst at
Truist Financial
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+6.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
67%
12 W / 6 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
78%
7 W / 2 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
22%
2 W / 7 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
22%
2 W / 7 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
6 W / 6 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
65%
11 W / 6 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 11, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$70.00
Est. +60%
|
$43.79 | $45.61 |
Pending
|
$35.51
-18.9%
|
| May 05, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$106.00
Est. +38%
|
$76.59 | $80.18 |
Pending
|
$71.38
-6.8%
|
| Apr 14, 2026 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$121.00
Est. +17%
|
$103.21 | $112.77 |
Pending
|
$112.46
+9.0%
|
| Mar 18, 2026 |
Arvinas Inc
ARVN
|
SELL |
$10.00
Est. +9%
|
$10.96 | $6.97 (Low) |
Target Met
|
$7.49
+31.7%
|
| Mar 09, 2026 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$50.00
Est. +74%
|
$28.78 | $45.61 |
Pending
|
$35.51
+23.4%
|
| Mar 03, 2026 |
Scholar Rock Holding Corp
SRRK
|
BUY |
$55.00
Est. +24%
|
$44.31 | $52.19 |
Pending
|
$45.92
+3.6%
|
| Feb 03, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$92.00
Est. +38%
|
$66.47 | $80.18 |
Pending
|
$71.38
+7.4%
|
| Dec 24, 2025 |
Incyte Corp.
INCY
|
BUY |
$103.00
Est. +2%
|
$100.91 | $112.29 |
Target Met
|
$101.98
+1.1%
|
| Dec 22, 2025 |
Cytokinetics Inc
CYTK
|
BUY |
$84.00
Est. +25%
|
$67.33 | $80.18 |
Pending
|
$71.38
+6.0%
|
| Dec 09, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$116.00
Est. +34%
|
$86.27 | $103.00 |
Pending
|
$85.59
-0.8%
|
| Dec 03, 2025 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$65.00
Est. +28%
|
$50.98 | $62.89 |
Pending
|
$56.24
+10.3%
|
| Nov 19, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,182.00
Est. +13%
|
$1,049.60 | $1,182.73 |
Bullseye Hit (±1%)
|
$1,129.59
+7.6%
|
| Oct 28, 2025 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$88.00
Est. +15%
|
$76.68 | $112.77 |
Target Met
|
$112.46
+46.7%
|
| Sep 09, 2025 |
Tourmaline Bio Inc
TRML
|
BUY |
$48.00
Est. +1%
|
$47.64 | $48.26 |
Bullseye Hit (±1%)
|
$47.98
+0.7%
|
| May 05, 2025 |
Arvinas Inc
ARVN
|
BUY |
$11.00
Est. +44%
|
$7.63 | $16.14 |
Target Met
|
$7.49
-1.8%
|
| Dec 05, 2024 |
Edgewise Therapeutics Inc
EWTX
|
BUY |
$50.00
Est. +58%
|
$31.57 | $35.25 |
Miss
|
$35.21
+11.5%
|
| Nov 22, 2024 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$60.00
Est. +29%
|
$46.46 | $93.25 |
Target Met
|
$112.46
+142.1%
|
| Nov 05, 2024 |
Keros Therapeutics Inc
KROS
|
BUY |
$100.00
Est. +61%
|
$62.02 | $72.37 |
Miss
|
$10.24
-83.5%
|
MBX Biosciences, Inc. Common Stock
MBX
May 11, 2026
Signal & Target
BUY
$70.00
Start Price
$43.79
Best Price (1Y)
$45.61
Current Price
$35.51
Return
-18.9%
Cytokinetics Inc
CYTK
May 05, 2026
Signal & Target
BUY
$106.00
Start Price
$76.59
Best Price (1Y)
$80.18
Current Price
$71.38
Return
-6.8%
Protagonist Therapeutics Inc
PTGX
Apr 14, 2026
Signal & Target
BUY
$121.00
Start Price
$103.21
Best Price (1Y)
$112.77
Current Price
$112.46
Return
+9.0%
Arvinas Inc
ARVN
Mar 18, 2026
Signal & Target
SELL
$10.00
Start Price
$10.96
Best Price (1Y)
$6.97
Current Price
$7.49
Return
+31.7%
MBX Biosciences, Inc. Common Stock
MBX
Mar 09, 2026
Signal & Target
BUY
$50.00
Start Price
$28.78
Best Price (1Y)
$45.61
Current Price
$35.51
Return
+23.4%
Scholar Rock Holding Corp
SRRK
Mar 03, 2026
Signal & Target
BUY
$55.00
Start Price
$44.31
Best Price (1Y)
$52.19
Current Price
$45.92
Return
+3.6%
Cytokinetics Inc
CYTK
Feb 03, 2026
Signal & Target
BUY
$92.00
Start Price
$66.47
Best Price (1Y)
$80.18
Current Price
$71.38
Return
+7.4%
Incyte Corp.
INCY
Dec 24, 2025
Signal & Target
BUY
$103.00
Start Price
$100.91
Best Price (1Y)
$112.29
Current Price
$101.98
Return
+1.1%
Cytokinetics Inc
CYTK
Dec 22, 2025
Signal & Target
BUY
$84.00
Start Price
$67.33
Best Price (1Y)
$80.18
Current Price
$71.38
Return
+6.0%
Kymera Therapeutics Inc
KYMR
Dec 09, 2025
Signal & Target
BUY
$116.00
Start Price
$86.27
Best Price (1Y)
$103.00
Current Price
$85.59
Return
-0.8%
Bristol-Myers Squibb Co.
BMY
Dec 03, 2025
Signal & Target
BUY
$65.00
Start Price
$50.98
Best Price (1Y)
$62.89
Current Price
$56.24
Return
+10.3%
Lilly(Eli) & Co
LLY
Nov 19, 2025
Signal & Target
BUY
$1,182.00
Start Price
$1,049.60
Best Price (1Y)
$1,182.73
Current Price
$1,129.59
Return
+7.6%
Protagonist Therapeutics Inc
PTGX
Oct 28, 2025
Signal & Target
BUY
$88.00
Start Price
$76.68
Best Price (1Y)
$112.77
Current Price
$112.46
Return
+46.7%
Tourmaline Bio Inc
TRML
Sep 09, 2025
Signal & Target
BUY
$48.00
Start Price
$47.64
Best Price (1Y)
$48.26
Current Price
$47.98
Return
+0.7%
Arvinas Inc
ARVN
May 05, 2025
Signal & Target
BUY
$11.00
Start Price
$7.63
Best Price (1Y)
$16.14
Current Price
$7.49
Return
-1.8%
Edgewise Therapeutics Inc
EWTX
Dec 05, 2024
Signal & Target
BUY
$50.00
Start Price
$31.57
Best Price (1Y)
$35.25
Current Price
$35.21
Return
+11.5%
Protagonist Therapeutics Inc
PTGX
Nov 22, 2024
Signal & Target
BUY
$60.00
Start Price
$46.46
Best Price (1Y)
$93.25
Current Price
$112.46
Return
+142.1%
Keros Therapeutics Inc
KROS
Nov 05, 2024
Signal & Target
BUY
$100.00
Start Price
$62.02
Best Price (1Y)
$72.37
Current Price
$10.24
Return
-83.5%